Selenium was investigated using human origin preadipocytes to see whether it possesses preventive or therapeutic effects for obesity. Unveiling the potential of selenium in the reduction of adipogenesis can help predict the therapeutic capabilities of selenium in obesity. In the present study, the molecular mechanism of the inhibition of adipogenesis by selenium was explored to unravel the involvement of the AMP-activated protein kinase. There is emerging evidence that AMPK, a sensor of cellular energy status, is a possible molecular target of controlling adipocyte differentiation on the basis of discovery that AMPK is responsible for the major metabolic responses to exercise, and integration of nutritional and hormonal signals to modulate feeding behavior or energy expenditure in the hypothalamus. Treatment of selenium resulted in inhibition of the adipocyte differentiation process and induction of mature apoptosis in 3T3-L1 adipocytes. W e hypothesized that selenium may exert anti-adipogenic potential though modulating AMPK. W e have found that selenium significantly activated AMPK and phosphorylated its substrate acetyl-CoA carboxylase (ACC-serine 79 ) during the inhibitory process of adipocytes. Also, the inhibition process of adipocyte differentiation by selenium was comparable to either reveratrol or a synthetic AMPK activator, AICAR (5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside). To evaluate the involvement of AMPK in anti-lipogensis, we applied AICAR and Compound C, an AMPK inhibitor, to 3T3-L1-adipocytes and found that AMPK is required for the adipocyte differentiation blocking process. These results suggest that selenium has a potential to control adipogenesis and that this effect is mediated by AMPK, an essential kinase for both inhibition of adipocyte differentiation and apoptosis of mature adipocytes.
Introduction
Selenium, an essential trace nutrient, has a variety of functions in cells including antioxidant properties. Dietary selenium supplementation has received a great deal of attention for its possible beneficial effects [1, 2] . Additionally, selenium has been shown to have anti-tumorigenic abilities, and other metabolic regulatory functions such as glucose homeostasis and lipid concentrations [3, 4] . Although numerous studies on functional aspects of selenium for the prevention of degenerative diseases have been carried out, anti-adipogenic effect of selenium has not been explored.
Identifying molecular basis for controlling adipocytes has an implication for therapeutic modalities of obesity development and obesity related metabolic consequences. The modulation of AMP-activated kinase (AMPK) has emerged as an important target for the prevention and treatment of atherosclerosis as well as potentially for obesity therapy [5, 6] . AMPK, a sensor of cellular energy status, emerges as a possible molecular candidate of controlling adipocyte differentiation [7] . Recently, controlling obesity and diabetes through the modulation of AMPK has gained a great deal of attention, because there is a general consensus that the major metabolic responses to exercise are mediated through AMPK [8] . Furthermore, considering increased use of selenium as a dietary supplement, it needs to be clarified the possible biological function of selenium on adipocytes. The aim of the present study was to evaluate the effects of selenium on adipocyte differentiation and induction of apoptosis through the activation of AMPK signaling. Our results show that selenium activates AMPK, inhibits adipocyte differentiation comparable to resveratrol or AICAR, and induces apoptosis of adipocytes. 
AMP-activated

Adipocyte differentiation
3T3-L1-preadipocyte cells were grown in 12-well plates, and adipocyte differentiation was induced for two days with hormonal mixtures containing 1M dexamethasone, 5 g/ml insulin, and 0.5 mM IBMX. After two days, the medium was changed to the normal medium containing insulin (5 g/ml).
Oil Red O staining
After completing differentiation, the cells were fixed with 3.5% formaldehyde for 20 min, and then the differentiated cells were stained with Oil Red O dye (Sigma-Aldrich).
Protein extract and Western blotting
The cells were washed with phosphate-buffered saline (PBS), scraped into lysis buffer (50mM Tris HCl [pH 7.4], -1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM NaF, 1 g/ml aprotinin, 1 g/ml leupeptin, and 1 g/ml pepstatin), and subjected to W estern blot analysis with specific antibodies.
Chromatin staining with Hoechst 33342
Cells were stained with 10 µM Hoechst 33342 dye (Sigma-Aldrich) for 30 min, and then cells were fixed with 3.7% para-formaldehyde for 15 min. After PBS (phosphoatebuffered saline) washing, the fluorescence intensity was assessed by fluorescence microscope.
Results
Inhibition of adipocyte differentiation was observed in 3T3-L1 adipocytes treated with selenium W e evaluated the effects of selenium on the inhibition of adipocyte differentiation. Cultured 3T3-L1 adipocytes were exposed to selenate at different doses (at day 0), and cell differentiation was performed with a hormonal cocktail contained medium. At day 6, differentiations were ended and droplets of lipid were detected by oil staining. The treatment of adipocytes with selenate markedly suppressed adipocyte differentiation (Fig. 1) . These results suggest that selenium might be an efficient blocker of adipocyte differentiation, and therefore, have a potential of anti-obesity agent.
Selenium also induced mature adipocyte apoptosis
The apoptotic ability of mature adipocytes were next evaluated, and 3T3-L1 adipocytes were differentiated with hormonal cocktail treatment, and mature cells were exposed to selenium. After treatment, apoptotic pattern was observed with hoechst 33342 dye, and the apoptotic bodies were found in selenium-exposed mature adipocytes ( Fig. 2A) .
Selenium was found to activate AMPK in the process of adipocyte differentiation blockage Blockage of adipocyte differentiation by selenium was comparable to the adipocyte differentiation inhibition by either resveratrol or AICAR
The inhibition of adipocyte differentiation of AMPK by selenium was comparable to the treatment with grape phytochemical resveratrol or AICAR, a synthetic AMPK activator in 3T3-L1 adipocytes (Fig. 3) . 
Discussion
Correct assessment of the underlying mechanisms of anti-obesity effect of dietary agent is inevitable in considering the application to human intervention trials. In the present study the molecular basis of selenium with emphasis on their ability to control intracellular signaling cascades of AMP activated kinase (AMPK) responsible for the inhibition of adipogenesis was investigated. The evolutionarily conserved serine/threonine kinase, AMPK, is known as a primary cellular homeostasis sensor and effecter modulating energy balance and a possible target molecule of anti-obesity [9] . Hypothalamic AMPK was found to integrate nutritional and hormonal signals modulating feeding behavior and energy expenditure [10] . Moreover, adipocyte-derived hormones such as leptin and adiponectin are shown to activate AMPK [11, 12] . The mechanism by which affects AMPK regulation with physiological stimuli or anti-obesity agents might present a promising target for the development of strategies for the treatment of obesity. In present study, we investigated the effects of selenium on adipocyte differentiation in relation to AMPK activation. We have observed that adipogenesis was induced during adipocyte differentiation by hormonal cocktail, and selenium significantly inhibited the process of adipocyte differentiation and led to mature adipocyte apoptosis. The previous report from our laboratory has shown the possibility of ROS as an upstream signal of AMPK in the process of adipocyte control by the naturally occurring compounds such as genistein, EGCG (epigallocatechin-3-gallate) and capsaicin [13] . From the present study it was suggested that the activation of AMPK was necessary for the inhibition of adipogenesis in 3T3-L1 cells, and AMPK is a novel and critical component of both inhibition of adipocyte differentiation and apoptosis of mature adipocyte by selenium implying AMPK as a prime target of obesity control. Obesity is considered to be resulting from the imbalance between energy intake and energy expenditure that may be linked to a pathologic overgrowth of adipose cells [22] . The mass of adipose tissue is thought to be modulated by the blocking of adipogenesis from precursors, and the control of the size of mature adipocytes.
Therefore, obesity is caused by the hypertrophy of adipocytes as well as the recruitment of new adipocytes from precursor cells, and these two processes are critical for the adipocyte differentiation [22] . AMPK is known to play a major role in energy homeostasis by coordinating adaptive responses in ATP-depleting metabolic states of exercise [8] .
Furthermore, the persistent activation of AMPK showed to be connected to p53-dependent cellular senescence suggesting its role as an intrinsic regulator of the cell cycle in mammalian cells [14] . Recently, AMPK cascades have emerged as novel targets for the treatment of obesity and type 2 diabetes. AMPK is known to be activated with 5-amino-imidazole-4-carboxamide riboside (AICAR), which is converted to a nucleotide that mimics the effect of AMP, and the long term treatment with AICAR prevented the development of diabetes in animal models [15] . Also, the proapoptotic potential of the activated was observed in the AMPK over-expressed conditions of various cells [16, 17] .
Our results show that selenium activates AMPK, blocks adipocyte differentiation comparable to resveratrol or AICAR, and induces apoptosis of adipocytes. The anti-proliferatory and lipolytic effects of selenium have been attributed to their ability to modulate various signaling pathways, specially, the control of cell proliferation and survival. However, the precise target of their anti-proliferatory effect remained unresolved. Here, we introduce AMPK as a possible main target of these compounds in their anti-obesity activity.
AMPK is activated by various stimuli including exercise, heat shock and ROS [15] . The activated for blocks the anabolic pathways and promotes catabolic pathway, and thus activation of AMPK is linked to inhibition of cell proliferation and apoptosis. AMPK is known to be involved in the oxidative stress-induced cellular apoptosis through the inhibition of specific protein trans-elongation factor 2 when it is phosphorylated [18, 19] . The more recent studies suggest that AMPK plays a critical role in the inhibition of cellular protein synthesis as well as stress-induced apoptosis [20] .
It has been reported that AMPK activation is necessary for the therapeutic effect of metformin and troglitazone [23] . The mechanism by which affects AMPK regulation with physiological stimuli or anti-obesity agents might present a promising target for the development of strategies for the treatment of obesity. AMPK cascades have been postulated to respond to the intracellular level of AMP or AMP:ATP ratio, and to be highly sensitive to the oxidative stress [21] . The exact mechanism to stimulate preadipocyte mitosis and differentiation in vivo remains exclusive. However, it is proposed that hypertrophy of fat cells grown beyond a certain size might propagate to differentiate by sending specific signals.
Adipocyte inducers stimulate preadipocytes to undergo mitotic clonal expansion before transcriptional activation of adipocyte genes before anchoring adipocyte phenotypes [24] . The results indicated that adipogenesis was induced during adipocyte differentiation by hormonal cocktail, and selenium inhibited the adipocyte differentiation of lead to apoptosis of mature adipocytes. Also we have tested whether AICAR has the similar effect on adipocyte differentiation and AMPK activation in comparision with selenium, and we have found that selenium and AICAR inhibited the differentiation and early clonal expansion of pre-adipocytes. W e have also found that AMPK inhibitor Compound C could block the inhibitory effect of AMPK on adipocyte differentiation. These results strongly suggested that the activation of AMPK was necessary for the inhibition of adipogenesis in 3T3-L1 cells, and AMPK is a novel and critical component in adipogenesis, also AMPK is necessary for the inhibition of both adipocyte differentiation and apoptosis of mature adipocyte by selenium and resveratrol implying its involvement in dietary agent-inhibited adipogenesis.
